What is the role of diuretics, such as Furosemide (Lasix), in managing dengue serositis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Diuretics in Dengue Serositis

Diuretics, particularly furosemide, should not be routinely used in dengue serositis as they may worsen intravascular volume depletion in a disease characterized by plasma leakage, potentially leading to shock and increased mortality. 1, 2, 3

Pathophysiology of Dengue Serositis and Fluid Management

  • Dengue virus infection can cause polyserositis (pleural effusion and ascites) due to increased capillary permeability and plasma leakage, which is the hallmark of severe dengue 1
  • The critical phase of dengue is characterized by intravascular fluid leakage into interstitial spaces and third spaces, which can lead to hemoconcentration and shock 3
  • Careful fluid management is essential in dengue, with the primary goal being to replace plasma losses with appropriate fluid and electrolyte solutions 1

Contraindications to Diuretic Use in Dengue

  • Diuretics can exacerbate the already compromised intravascular volume status in dengue patients, potentially precipitating or worsening shock 3
  • High volumes of intravenous fluids (>2000 mL/day) are associated with higher risk of developing severe dengue in patients with warning signs, suggesting that fluid management must be carefully balanced 4
  • Diuretics like furosemide increase urinary excretion of potassium, which can lead to hypokalemia, further complicating the management of dengue patients 5

Limited Indications for Diuretics in Dengue

  • Diuretics should be reserved for specific situations in dengue management, such as:

    • Acute pulmonary edema with respiratory distress that is unresponsive to fluid restriction 6, 7
    • Fluid overload states following excessive fluid resuscitation 8
    • Patients with underlying cardiac or renal conditions who develop fluid overload during dengue management 8
  • When diuretics are deemed necessary, they should be administered with extreme caution:

    • Start with low doses and titrate according to clinical response 8
    • Monitor vital signs, urine output, and electrolytes frequently 9
    • Consider discontinuation if signs of hypovolemia develop 9

Evidence for Diuretic Use in Specific Scenarios

  • A small study showed that furosemide infusion (0.05-0.1 mg/kg/hour for 48 hours) improved outcomes in dengue patients with ARDS, suggesting a potential role in this specific complication 7
  • Loop diuretics may be used in the presence of signs of fluid overload related to blood transfusion in dengue patients requiring transfusion therapy 8

Recommended Approach to Fluid Management in Dengue Serositis

  • The mainstay of treatment for dengue serositis is appropriate fluid replacement rather than diuresis 1, 3
  • Early and effective replacement of plasma losses with crystalloids and colloids is the recommended approach 1
  • Crystalloids should be given as boluses as rapidly as possible in profound shock, with colloids indicated in patients with massive plasma leakage 1
  • Frequent monitoring of vital signs and hematocrit is crucial in evaluating treatment response 1

Potential Complications of Inappropriate Diuretic Use

  • Worsening of shock due to decreased intravascular volume 3
  • Electrolyte imbalances, particularly hypokalemia 5
  • Metabolic alkalosis 8
  • Acute kidney injury due to decreased renal perfusion 8

Conclusion

Diuretics have a very limited role in the management of dengue serositis and should be used with extreme caution only in specific scenarios of fluid overload or respiratory distress. The cornerstone of dengue management remains appropriate fluid replacement to counteract plasma leakage, with careful monitoring of hemodynamic status.

References

Research

Management of dengue fever in ICU.

Indian journal of pediatrics, 2001

Research

Dengue in the Western Hemisphere.

Infectious disease clinics of North America, 1994

Research

FLUID AND HEMODYNAMIC MANAGEMENT IN SEVERE DENGUE.

The Southeast Asian journal of tropical medicine and public health, 2015

Guideline

Medication-Induced Hypokalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Furosemide Administration via Intramuscular Route

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.